Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors

Journal of the American College of Surgeons

Volumn 195, Issue 6, 2002, Pages 774-781

  Schell, Scott R ^a,b   Wessels, Frank J ^a,b   Abouhamze, Amer ^a,b   Moldawer, Lyle L ^a,b   Copeland III, Edward M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER DISEASE; LIVER FAILURE; LIVER TUMOR; MALE; MORTALITY; PRIORITY JOURNAL; RADIOFREQUENCY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CATHETER ABLATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0036904378     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01333-9     Document Type: Article

References (36)

1. Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res 2001;95:8-12.
2. Rose DM, Allegra DP, Bostick PJ, et al. Radiofrequency ablation: A novel primary and adjunctive ablative technique for hepatic malignancies. Am Surg 1999;65:1009-1014.
3. Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997;122:1154-1155.
4. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients [see comments]. Ann Surg 1999;230:1-8.
5. Fong Y, Kemeny N, Paty P, et al. Treatment of colorectal cancer: Hepatic metastasis. Semin Surg Oncol 1996;12:219-252.
6. Kavolius J, Fong Y, Blumgart I.H. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am 1996;5:337-352.
7. Fong Y, Blumgart LH. Surgical options in the treatment of hepatic metastases for colorectal cancer. Curr Probl Surg 1996;35:336-413.
8. Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery. Semin Surg Oncol 1998:14:156-162.
9. Stewart GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: Double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995;32:215-219.
10. Haddad FF, Chapman WC, Wright JK, et al. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998;75:103-108.
11. Bagia JS, Perera DS, Morris DL. Renal impairment in hepatic cryotherapy. Cryobiology 1998;36:263-267.
12. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999;23:113-114.
13. Bellon JM, Manzano L, Larrad A, et al. Endocrine and immune response to injury after open and laparoscopic cholecystectomy. Int Surg 1998;83:24-27.
14. Berguer R, Bravo N, Bowyet M, Ferrick D. Measurement of intracellular gamma-interferon, interleukin-4, and interleukin-10 levels in patients following laparoscopic cholecystectomy. J Invest Surg 2000;13:161-167.
15. Helmy SA, Wahby MA, El-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production. Anaesthesia 1999;54:733-738.
16. Lemaire LC, van der Poll T, van Lanschot JJ, et al. Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia. J Clin Immunol 1998;18:414-420.
17. Welborn MB, Oldenburg HS, Hess PJ, et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 2000;28:3191-3197.
18. Washington K, Debelak JP, Gobbell C, et al. Hepatic cryoablation-induced acute lung injury. Histopathologic findings. J Surg Res 2001;95:1-7.
19. Chapman WC, Debelak JP, Wright Pinson C, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000;231:752-761.
20. Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: Pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000;135:672-673.
21. Blackwell TS, Debelak JP, Venkatakrishnan A, et al. Acute lung injury after hepatic cryoablation: Correlation with NF-kappa B activation and cytokine production. Surgery 1999;126:518-526.
22. DeLand FH, North WA. Relationship between liver size and body size. Radiology 1968;91:1195-1198.
23. van der Poll T, Coyle SM, Moldawer IL, Lowry SF. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis 1996;174:1356-1360.
24. Fong YM, Marano MA, Moldawer LL, et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990;85:1896-1904.
25. Welborn MB III, Douglas WG, Abouhamze Z, et al. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-I (IL-1) dependent organ injury in the mouse. Shock 1996;6:171-176.
26. Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-4849.
27. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 1998.
28. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 1986;100:278-284.
29. Adam R, Majno P, Castaing D, et al. Treatment of irresectable liver tumours by percutaneous ctyosurgery. Br J Surg 1998;85:1493-1494.
30. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998;228:201-208.
31. Shafir M, Shapiro R, Sung M, et al. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996;171:27-31.
32. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998;14:163-170.
33. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998;14:171-174.
34. Seifert JK, Finlay I, Armstrong N, Morris DL. Thrombocytopenia and cytokine release following hepatic cryosurgery [abstract]. Aust N Z J Surg 1998;68:526.
35. Goldblum SE, Hennig B, Jay M, et al. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect Immun 1989;57:1218-1226.
36. Ferrari-Baliviera E, Mealy K, Smith RJ, Wilmore DW. Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg 1989;124:1400-1405.